A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: A randomized, double-blind, two-period crossover study in healthy volunteers
Authors:
- 31 January 2009
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 31 (1) , 108-114
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended Release 30 mg versus Cyclobenzaprine Immediate Release 10 mg Three Times Daily in Healthy Young AdultsClinical Drug Investigation, 2008
- Medications for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice GuidelineAnnals of Internal Medicine, 2007
- Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphoneCurrent Medical Research and Opinion, 2007
- Persistence With Once-Daily Versus Twice-Daily Bupropion for the Treatment of Depression in a Large Managed-Care PopulationAmerican Journal of Therapeutics, 2007
- Efficacy of a low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: Results of two placebo-controlled trialsClinical Therapeutics, 2003
- Cyclobenzaprine Pharmacokinetics, Including the Effects of Age, Gender, and Hepatic InsufficiencyThe Journal of Clinical Pharmacology, 2002
- Cyclobenzaprine and Back PainArchives of internal medicine (1960), 2001
- Conservative Treatment of Acute and Chronic Nonspecific Low Back PainSpine, 1997
- Cyclobenzaprine: a possible mechanism of action for its muscle relaxant effectCanadian Journal of Physiology and Pharmacology, 1981
- Cyclobenzaprine: A novel centrally acting skeletal muscle relaxantNeuropharmacology, 1975